21 results on '"Ata Siddiqui"'
Search Results
2. Acute Myelopathy in Childhood
- Author
-
Giulia Bravar, Aphra Luchesa Smith, Ata Siddiqui, and Ming Lim
- Subjects
myelopathy ,myelitis ,demyelination ,spinal cord injury ,Pediatrics ,RJ1-570 - Abstract
Acute myelopathy presenting in childhood can be clinically classified based on the location of injury (with resulting spinal syndrome) or the cause (broadly traumatic or non-traumatic). Types of nontraumatic myelopathy include ischaemic, infectious, inflammatory, nutritional, and metabolic causes, some of which may be part of a systemic illness such as systemic lupus erythematosus or a demyelinating disease such as multiple sclerosis. Nonaccidental injury is an important consideration in cases of traumatic myelopathy, which may often be associated with other injuries. Assessment should include neuroimaging of the brain and spinal cord, with further investigations targeted based on the most likely differential diagnoses; for example, a child with suspected demyelinating disease may require specialist cerebrospinal fluid and serological testing. Management also will differ based on the cause of the myelopathy, with several of these treatments more efficacious with earlier initiation, necessitating prompt recognition, diagnosis, and treatment of children presenting with symptoms of a myelopathy. Important components of holistic care may include physiotherapy and occupational therapy, with multidisciplinary team involvement as required (for example psychological support or specialist bowel and bladder teams).
- Published
- 2021
- Full Text
- View/download PDF
3. Idiopathic Hypertrophic Pachymeningitis: Does Earlier Treatment Improve Outcome?
- Author
-
Emilia Rizzo, Ailsa Elizabeth Ritchie, Vinay Shivamurthy, Ata Siddiqui, and Ming Lim
- Subjects
dural thickening ,cranial neuropathy ,immunotherapy ,sarcoid ,steroids ,visual failure ,Pediatrics ,RJ1-570 - Abstract
Background/goal: Hypertrophic pachymeningitis is a rare chronic inflammatory disorder characterized by marked fibrous thickening of the cerebral and/or spinal dura mater. This condition has largely been reported in adults, but there are very few reports in children. Methods: We describe a 14-year-old boy with idiopathic hypertrophic pachymeningitis, who presented with deteriorating vision on a background of severe headache. We evaluated pediatric cases of hypertrophic pachymeningitis and compared treatments and their relation to outcomes. Results: There are only eleven pediatric cases of hypertrophic pachymeningitis reported in the literature. In the patients treated with steroids either at presentation or subsequent relapses, a good response was reported. In the cases with delayed initiation of steroid treatment, this was often related to an incomplete recovery. In our patient, this delay may have contributed to his poor visual outcome. Conclusions: Early initiation of steroid treatment in children with idiopathic hypertrophic pachymeningitis may improve outcomes.
- Published
- 2020
- Full Text
- View/download PDF
4. Progress in the Management of Paediatric-Onset Multiple Sclerosis
- Author
-
Aphra Luchesa Smith, Christina Benetou, Hayley Bullock, Adam Kuczynski, Sarah Rudebeck, Katie Hanson, Sarah Crichton, Kshitij Mankad, Ata Siddiqui, Susan Byrne, Ming Lim, and Cheryl Hemingway
- Subjects
demyelination ,disease-modifying treatment ,neurocognitive ,neurodisability ,relapse ,Pediatrics ,RJ1-570 - Abstract
Considerable progress has been made in the understanding and treatment of paediatric-onset multiple sclerosis (POMS); how this has translated into more effective care is less well understood. Here, we evaluate how recent advances have affected patient management and outcomes with a retrospective review of POMS patients managed at two paediatric neuroimmunology centres. Two cohorts, seen within a decade, were compared to investigate associations between management approaches and outcomes. Demographic, clinical and neurocognitive data were extracted from case notes and analysed. Of 51 patients, 24 were seen during the period 2007–2010 and 27 during the period 2015–2016. Median age at onset was 13.7 years; time from symptom onset to diagnosis was 9 months. Disease-modifying therapies were commenced in 19 earlier-cohort and 24 later-cohort patients. Median time from diagnosis to treatment was 9 months for earlier vs. 3.5 months in later patients (p = 0.013). A wider variety of treatments were used in the later cohort (four medications earlier vs. seven in the later and two clinical trials), with increased quality of life and neurocognitive monitoring (8% vs. 48% completed PedsQL quality of life inventory; 58% vs. 89% completed neurocognitive assessment). In both cohorts, patients were responsive to disease-modifying therapy (mean annualised relapse rate pre-treatment 2.7 vs. 1.7, mean post-treatment 0.74 vs. 0.37 in earlier vs. later cohorts). In conclusion, over the years, POMS patients were treated sooner with a wider variety of medications and monitored more comprehensively. However, this hugely uncontrolled cohort did not allow us to identify key determinants for the improvements observed.
- Published
- 2020
- Full Text
- View/download PDF
5. Coronavirus Disease 2019 (COVID-19)–Associated Rhino-Orbito-Cerebral Mucormycosis: A Multi-Institutional Retrospective Study of Imaging Patterns
- Author
-
Sharath Kumar GG, Saikant Deepalam, Ata Siddiqui, Chaitra P. Adiga, Savith Kumar, Shivakumar Swamy Shivalingappa, Ullas V. Acharya, Lakshmikanth N. Goolahally, Saksham Sharma, Dhilip Andrew, Pradeep Hosmani, Satish Nair, Gaurav Medikeri, Ravi Mohan Rao, Jagadish B. Agadi, Sujit Kumar, Gurucharan Adoor, Suryanarayana Sharma, Raghuraj Hegde, Jitender Saini, and Karthik Kulanthaivelu
- Subjects
Male ,Antifungal Agents ,SARS-CoV-2 ,Orbital Diseases ,COVID-19 ,Humans ,Mucormycosis ,Female ,Surgery ,Neurology (clinical) ,Middle Aged ,Pandemics ,Retrospective Studies - Abstract
Mucormycosis infection of the maxillofacial region and brain has been associated with coronavirus disease 2019 (COVID-19) infection. Mucormycosis was relatively a rare infection before COVID-19, and imaging findings are not very well described.A retrospective imaging study of 101 patients diagnosed with COVID-19-associated mucormycosis by histopathology and/or culture was performed. All patients underwent computed tomography and/or magnetic resonance imaging based on the clinical condition of the patient and on consensus decision by the team of treating physicians. A simple 3-stage classification system based on imaging findings was adopted.One hundred one cases were included in the final analysis (mean age = 55.1 years; male/female ratio = 67:34). The affected patients had diabetes in 94% of the instances (n = 95), 80.1% (n = 81) received steroids), whereas 59.4% (n = 60) patients received supplemental oxygen. The majority underwent surgical intervention, whereas in 6 cases, patients were treated with antibiotic regimens. Sixty subjects improved following therapy, whereas 18 eventually succumbed to the illness. We noted a significant positive correlation between the imaging stage and outcomes. No association was seen between other clinical parameters and final clinical outcomes. Salient imaging findings include lack of normal sinonasal mucosal enhancement, perisinus inflammation, ischemic optic neuropathy, perineural spread, pachymeningeal enhancement, and presence of strokes.We describe the imaging findings in the largest cohort of patients with rhino-orbito-cerebral mucormycosis in the context of the current COVID-19 pandemic. A simplified staging system described here is helpful for standardized reporting and carries prognostic information.
- Published
- 2022
- Full Text
- View/download PDF
6. Guidelines for magnetic resonance imaging in pediatric head and neck pathologies: a multicentre international consensus paper
- Author
-
Felice, D'Arco, Livja, Mertiri, Pim, de Graaf, Bert, De Foer, Katarina S, Popovič, Maria I, Argyropoulou, Kshitij, Mankad, Hervé J, Brisse, Amy, Juliano, Mariasavina, Severino, Sofie, Van Cauter, Mai-Lan, Ho, Caroline D, Robson, Ata, Siddiqui, Steve, Connor, Sotirios, Bisdas, and Lennyn, Alban
- Subjects
Consensus ,Head and Neck Neoplasms ,Humans ,Child ,Head ,Magnetic Resonance Imaging ,Neck - Abstract
The use of standardized imaging protocols is paramount in order to facilitate comparable, reproducible images and, consequently, to optimize patient care. Standardized MR protocols are lacking when studying head and neck pathologies in the pediatric population. We propose an international, multicenter consensus paper focused on providing the best combination of acquisition time/technical requirements and image quality. Distinct protocols for different regions of the head and neck and, in some cases, for specific pathologies or clinical indications are recommended. This white paper is endorsed by several international scientific societies and it is the result of discussion, in consensus, among experts in pediatric head and neck imaging.
- Published
- 2022
7. Radiological Cerebrospinal Posterior Reversible Encephalopathy Syndrome Mimicking Acute Disseminated Encephalomyelitis in a Neurologically Asymptomatic Child
- Author
-
Christopher J.D. Reid, Christina Benetou, Ming K. Lim, and Ata Siddiqui
- Subjects
Pathology ,medicine.medical_specialty ,business.industry ,Posterior reversible encephalopathy syndrome ,medicine.disease ,Asymptomatic ,Developmental Neuroscience ,Neurology ,Neuroimaging ,Radiological weapon ,Pediatrics, Perinatology and Child Health ,Acute disseminated encephalomyelitis ,Medicine ,Neurology (clinical) ,medicine.symptom ,business - Published
- 2020
- Full Text
- View/download PDF
8. Cerebral vasculopathy in childhood neurofibromatosis type 2: cause for concern?
- Author
-
Shazia K. Afridi, Vijeya Ganesan, Cheryl Hemingway, Karine Lascelles, Rosalie E. Ferner, and Ata Siddiqui
- Subjects
Pediatrics ,medicine.medical_specialty ,Bevacizumab ,medicine.diagnostic_test ,business.industry ,Magnetic resonance imaging ,medicine.disease ,Haemorrhagic stroke ,Magnetic resonance angiography ,03 medical and health sciences ,0302 clinical medicine ,Increased risk ,Developmental Neuroscience ,030220 oncology & carcinogenesis ,Vestibular Schwannomas ,Pediatrics, Perinatology and Child Health ,otorhinolaryngologic diseases ,medicine ,Neurology (clinical) ,Neurofibromatosis ,Neurofibromatosis type 2 ,business ,030217 neurology & neurosurgery ,medicine.drug - Abstract
Unlike adult neurofibromatosis type 2 (NF2), which presents with symptoms related to bilateral vestibular schwannomas, children with NF2 most frequently present with ocular, dermatological, and neurological symptoms. Arteriopathy, a well-established feature in neurofibromatosis type 1, is not a widely recognized feature of NF2. Here we report three children with NF2 with cerebral arteriopathy and/or arterial ischaemic stroke. Bevacizumab, a vascular endothethial growth factor inhibitor, is an established treatment for rapidly growing vestibular schwannomas; however, it carries a risk of both ischaemic and haemorrhagic stroke. Thus, the role of screening and risk to benefit ratio of bevacizumab in NF2 merit further consideration. WHAT THIS PAPER ADDS: Children with neurofibromatosis type 2 (NF2) may be at increased risk of cerebral vasculopathy and arterial ischaemic stroke. Targeted magnetic resonance angiography should be performed in children with NF2 who are being considered for bevacizumab therapy.
- Published
- 2018
- Full Text
- View/download PDF
9. Clinical presentation and prognostic indicators in 100 adults and children with neurofibromatosis 1 associated non-optic pathway brain gliomas
- Author
-
Ata Siddiqui, Darren Hargrave, Susan Byrne, Steve Connor, Rosalie E. Ferner, and Karine Lascelles
- Subjects
Adult ,Male ,Cancer Research ,medicine.medical_specialty ,Thalamic tumour ,Neurofibromatosis 1 ,Neurology ,Adolescent ,Epidemiology ,Malignancy ,Lesion ,Young Adult ,03 medical and health sciences ,0302 clinical medicine ,Glioma ,medicine ,Humans ,Pilocytic astrocytoma ,Neurofibromatosis ,Child ,Proportional Hazards Models ,Brain Neoplasms ,Proportional hazards model ,business.industry ,Neurooncology ,Brain ,Brain tumour ,Middle Aged ,Prognosis ,medicine.disease ,Surgery ,Oncology ,Child, Preschool ,030220 oncology & carcinogenesis ,Multivariate Analysis ,Clinical Study ,Female ,Neurology (clinical) ,Radiology ,medicine.symptom ,Neurofibromatosis type 1 (NF1) ,business ,030217 neurology & neurosurgery ,Follow-Up Studies - Abstract
Type 1 Neurofibromatosis (NF1) is a common autosomal dominant condition, with a major impact on the nervous system, eye, bone, and skin, and a predisposition to malignancy. At present it is not possible to predict clinically or on imaging, whether a brain tumour will remain indolent or undergo high-grade change. There are no consensus guidelines on the follow-up of non-optic pathway glioma (non-OPG) tumours in NF1. One hundred patients from the National NF1 Service with generalised NF1 and a diagnosis of non-OPG glioma were followed up for a median time of 63 months after glioma detection. Forty-two patients underwent surgical intervention. Ninety-one percent (38) of those requiring surgery did so within 5 years of diagnosis of glioma. Serial neuroimaging was undertaken in 88 patients. In 66 (75%), the lesion on the scan was stable or had improved at follow-up. High-grade lesions were present in five patients and were strongly associated with tumours in the thalamus (p = 0.001). Five patients died during follow-up. The diagnosis of high-grade glioma had a HR of 99.7 (95% CI 11.1–898.9, p
- Published
- 2017
- Full Text
- View/download PDF
10. An unusual neuroimaging finding and response to immunotherapy in a child with genetically confirmed vanishing white matter disease
- Author
-
Rahul Singh, Ming K. Lim, John H. Livingston, Ian R. Berry, and Ata Siddiqui
- Subjects
Pathology ,medicine.medical_specialty ,medicine.medical_treatment ,Encephalopathy ,Neuroimaging ,White matter ,03 medical and health sciences ,0302 clinical medicine ,Lumbar ,Adrenal Cortex Hormones ,030225 pediatrics ,Edema ,medicine ,Humans ,Genetic Testing ,Brain Diseases ,business.industry ,Leukodystrophy ,Cranial nerves ,Immunoglobulins, Intravenous ,General Medicine ,Immunotherapy ,medicine.disease ,Magnetic Resonance Imaging ,White Matter ,medicine.anatomical_structure ,Child, Preschool ,Pediatrics, Perinatology and Child Health ,Female ,Neurology (clinical) ,medicine.symptom ,business ,030217 neurology & neurosurgery ,Brain Stem - Abstract
Background We present an unusual neuroimaging finding in a young girl with genetically confirmed vanishing white matter disease and a possible response to immunotherapy. Methods and results 2.5 yr old girl, presented with acute onset unsteadiness and encephalopathy following a viral illness. MRI showed global symmetric white matter abnormality, with symmetric enhancement of cranial nerves (III and V) and of cervical and lumbar roots. She received immunotherapy for her encephalopathic illness with white matter changes. Follow up neuroimaging showed resolution of white matter edema and resolution of the change in the brainstem. Genetic testing confirmed a diagnosis of vanishing white matter disease (VWMD). Conclusion Craniospinal nerve enhancement and possible response to immunotherapy has not been described in vanishing white matter disease.
- Published
- 2017
- Full Text
- View/download PDF
11. Using Diffusion-Weighted Magnetic Resonance Imaging to Confirm a Diagnosis of Posterior Ischaemic Optic Neuropathy: Two Case Reports and Literature Review
- Author
-
Mitchell Lawlor, Paul Holmes, Ayyaz Quddus, Gordon T. Plant, and Ata Siddiqui
- Subjects
Prolonged Surgery ,medicine.medical_specialty ,genetic structures ,business.industry ,Infarction ,Context (language use) ,Review ,medicine.disease ,eye diseases ,Posterior ischaemic optic neuropathy ,Surgery ,Ophthalmology ,Giant cell arteritis ,Ophthalmic artery ,medicine.artery ,medicine ,Pancreatitis ,Neurology (clinical) ,Radiology ,business ,Diffusion MRI - Abstract
Posterior ischaemic optic neuropathy is a rare cause of visual loss believed to be due to infarction in the territory of the pial branches of the ophthalmic artery. The disorder most commonly occurs in the context of prolonged surgery or giant cell arteritis, and the absence of clinical signs in the eye means that the diagnosis is one of exclusion. Here, we present two cases studies of patients who developed posterior ischaemic optic neuropathy confirmed by the observation of secondary changes on diffusion-weighted imaging sequences. In the first case visual loss followed robotic pelvic surgery, and in the second case it was associated with multiorgan dysfunction secondary to severe pancreatitis. Our cases demonstrate that in the right clinical context, diffusion-weighted imaging can provide a positive diagnosis of acute posterior ischaemic optic nerve injury in the acute phase.
- Published
- 2015
- Full Text
- View/download PDF
12. Reversible cerebral vasoconstriction syndrome: a rare cause of postpartum headache
- Author
-
Kate Wiles, Catherine Nelson-Piercy, Ross Nortley, Paul Holmes, and Ata Siddiqui
- Subjects
Adult ,Constriction, Pathologic ,medicine ,Humans ,Vasospasm, Intracranial ,Nimodipine ,medicine.diagnostic_test ,business.industry ,Postpartum Period ,Headache ,Magnetic resonance imaging ,General Medicine ,medicine.disease ,Magnetic Resonance Imaging ,Reversible cerebral vasoconstriction syndrome ,Cerebral Angiography ,Postpartum headache ,Anesthesia ,Female ,Subarachnoid haemorrhage ,Neurology (clinical) ,medicine.symptom ,business ,Vasoconstriction ,Postpartum period ,medicine.drug ,Cerebral angiography - Abstract
We describe two women presenting with severe postpartum headache associated with hypertension but with no other signs or investigation results to suggest pre-eclampsia. In one case, the headache was associated with atypical subarachnoid haemorrhage. The variable nature of the headache and the degree of associated hypertension raised the clinical suspicion of reversible cerebral vasoconstriction syndrome, confirmed on MR angiography. Both patients took nimodipine until the cerebral vasoconstriction had resolved radiologically.
- Published
- 2015
- Full Text
- View/download PDF
13. Magnetic resonance imaging features of large endolymphatic sac compartments: audiological and clinical correlates
- Author
-
James R. Tysome, A Fitzgerald-O'Connor, Ruth L. O'Gorman, Steve Connor, Dan Jiang, A Lee, and Ata Siddiqui
- Subjects
Adult ,Male ,Adolescent ,Tertiary referral centre ,Statistics, Nonparametric ,Endolymphatic sac ,Young Adult ,Internal auditory meatus ,Image Processing, Computer-Assisted ,medicine ,Humans ,Child ,Cochlear implantation ,Cochlear modiolus ,Pendred syndrome ,Aged ,Retrospective Studies ,medicine.diagnostic_test ,business.industry ,Infant ,Reproducibility of Results ,Labyrinthine Fluids ,Magnetic resonance imaging ,General Medicine ,Anatomy ,Hearing Loss, Sudden ,Middle Aged ,Prognosis ,medicine.disease ,Cochlear Implantation ,Magnetic Resonance Imaging ,medicine.anatomical_structure ,Otorhinolaryngology ,Child, Preschool ,Disease Progression ,Audiometry, Pure-Tone ,Female ,Imaging Signal ,Endolymphatic Sac ,business - Abstract
Objectives:(1) To study the prevalence and characteristics of large endolymphatic sac internal compartments on thin-section T2- and T2*-weighted magnetic resonance imaging, and to relate these to other large endolymphatic sac magnetic resonance imaging features, and (2) to correlate the compartment imaging features, endolymphatic sac size and labyrinthine anomalies with the patients' clinical and audiological data.Method:Magnetic resonance imaging studies for 38 patients with large endolymphatic sac anomalies were retrospectively reviewed in a tertiary referral centre. Endolymphatic sac compartment presence, morphology and imaging signal were assessed. Endolymphatic sac size and labyrinthine anomalies were also recorded. Endolymphatic sac compartments and other imaging features were correlated with clinical and audiological data.Results:Compartments were present in 57 per cent of the imaged endolymphatic sacs, but their presence alone did not correlate with other imaging features or clinical data. The endolymphatic sac : internal auditory meatus signal ratio was associated with a history of sudden or fluctuating hearing loss. Hearing loss correlated with opercular and extraosseous endolymphatic sac size measurements. A larger midpoint intraosseous endolymphatic sac size was associated with clear fluid loss at cochlear implantation.Conclusion:The magnetic resonance imaging characteristics of large endolymphatic sac compartments have been defined. The endolymphatic sac size and distal compartment signal should be recorded, as these provide prognostic information and assist the planning of appropriate interventions.
- Published
- 2012
- Full Text
- View/download PDF
14. O135 Sensory evoked potentials and central motor conduction times in children with dystonia help predict outcomes from Deep Brain Stimulation (DBS)
- Author
-
Hortensia Gimeno, Graham E. Holder, Denise Flexney-Briscoe, Kerry R. Mills, Ata Siddiqui, Markus C. Elze, Jean-Pierre Lin, Richard Selway, Verity M. McClelland, and Doreen Fialho
- Subjects
Dystonia ,Deep brain stimulation ,business.industry ,medicine.medical_treatment ,Sensory system ,medicine.disease ,Sensory Systems ,Neuromodulation (medicine) ,nervous system diseases ,Transcranial magnetic stimulation ,medicine.anatomical_structure ,Neurology ,Somatosensory evoked potential ,Physiology (medical) ,Anesthesia ,Scalp ,medicine ,Mann–Whitney U test ,Neurology (clinical) ,business - Abstract
Objectives Deep Brain Stimulation (DBS) of the Globus Pallidus Internus produces dramatic benefits in primary dystonia. Improvements in patients with secondary dystonia are smaller and vary markedly between individuals. Predictive markers are lacking. This study tests the hypothesis that Somatosensory Evoked Potentials (SEPs) and Central Motor Conduction Times (CMCT) may predict outcome from DBS in childhood dystonia. Methods Data were obtained from 180 consecutive children with dystonia undergoing multidisciplinary assessment for DBS (mean age 10 years; range 2.5–19). CMCT to each limb was obtained using Transcranial Magnetic Stimulation and the F-wave method. Median and posterior tibial nerve SEPs were recorded over contralateral and midline centro-parietal scalp. Technically unsatisfactory data were excluded. Structural abnormalities were assessed with cranial MRI. Outcome from DBS at 1 year was assessed as percentage improvement in Burke-Fahn-Marsden Dystonia Rating Scale (BFMDRS-m). Results Satisfactory CMCT data were obtained from 146 children, of whom 28 (19%) had an abnormal CMCT to at least one limb. Satisfactory cortical SEP data were obtained from 100 children, of whom 47 had at least one abnormal cortical potential. Abnormal CMCTs and SEPs were both observed more frequently in secondary than primary/primary plus dystonia (CMCT abnormal in 22% secondary versus 9% primary patients; SEP abnormal in 53% secondary vs 24% primary patients). Of children proceeding to DBS, improvement in BFMDRS-m was greater in those with normal (n = 78) than abnormal CMCT (n = 11) (Mann Whitney test p = 0.002) and was also greater in those with normal (n = 35) versus abnormal SEPs (n = 16) (Mann Whitney test p = 0.001). On sub-group analysis, the relationships between CMCT/SEPs and BFMDRS-m scores were independent of aetiology (primary versus secondary) and MRI findings (normal versus abnormal). Discussion/Conclusion CMCTs and SEPs provide objective evidence of motor and sensory pathway dysfunction in children with dystonia and relate to DBS outcome. These markers may therefore contribute to patient selection and counselling of families about potential benefit from neuromodulation. Significance We identify neurophysiological markers that can guide the selection of patients for DBS.
- Published
- 2017
- Full Text
- View/download PDF
15. Encephalopathy and SCN1A mutations
- Author
-
Shan Tang, Ata Siddiqui, Elaine Hughes, Ming K. Lim, Karine Lascelles, and Jean-Pierre Lin
- Subjects
Pathology ,medicine.medical_specialty ,Mutation ,business.industry ,Encephalopathy ,Ischemia ,Status epilepticus ,medicine.disease ,medicine.disease_cause ,Brain ischemia ,Sepsis ,Epilepsy ,Neurology ,Neuroimaging ,Anesthesia ,medicine ,Neurology (clinical) ,medicine.symptom ,business - Abstract
We describe three children with genetically different sodium channel alpha 1 subunit (SCN1A) mutation associated epilepsy who experienced a sudden and sustained neurologic regression following status epilepticus in two and acute sepsis in one. Neuroimaging showed evidence of cerebral ischemia in one, but the other two cases showed cerebellar signal abnormalities. The selectivity of cerebellar white matter change suggests a different mechanism of injury or increased susceptibility of this brain region to injury in at least some patients with SCN1A mutations. This report adds to the spectrum and mechanism of acute neurologic deterioration and functional deficit associated with SCN1A mutations, which remains to be fully understood.
- Published
- 2011
- Full Text
- View/download PDF
16. Holmes’ tremor from a lesion of the red nucleus in association with cerebral toxoplasmosis
- Author
-
Kit Wu, Paul Holmes, Thomasin C. Andrews, and Ata Siddiqui
- Subjects
Pathology ,medicine.medical_specialty ,Ataxia ,Red nucleus ,business.industry ,Rubral tremor ,medicine.disease ,Botulinum toxin ,nervous system diseases ,Lesion ,Midbrain ,Holmes tremor ,Hemiparesis ,Neurology ,Anesthesia ,medicine ,Neurology (clinical) ,medicine.symptom ,business ,medicine.drug - Abstract
Holmes’ tremor (also known as rubral or midbrain tremor) is a rare movement disorder characterized by a low frequency tremor of the upper extremity at rest and upon voluntary movement. This report presents the case of a patient who developed a tremor of her right arm, with hemiparesis and ataxia as a result of systemic and cerebral toxoplasmosis in association with AIDS. MRI brain imaging showed a lesion in the contralateral red nucleus in the rostral midbrain, consistent with toxoplasmosis, and confirming the diagnosis of a Holmes’ tremor. The patient responded well, symptomatically, to botulinum toxin (Botox) injections. This case illustrates the importance of neuroimaging in diagnosis of tremor disorders.
- Published
- 2014
- Full Text
- View/download PDF
17. Perfusion MRI Demonstrates Crossed-Cerebellar Diaschisis in Sickle Cell Disease
- Author
-
Ruth L. O'Gorman, Jozef Jarosz, Ata Siddiqui, and David C. Alsop
- Subjects
Male ,Perfusion scanning ,Anemia, Sickle Cell ,Severity of Illness Index ,Developmental Neuroscience ,Cerebellum ,Image Processing, Computer-Assisted ,medicine ,Humans ,Child ,Cerebrum ,Diaschisis ,Cerebral infarction ,business.industry ,Cerebral Infarction ,medicine.disease ,Magnetic Resonance Imaging ,Crossed cerebellar diaschisis ,Neurology ,Magnetic resonance perfusion imaging ,Pediatrics, Perinatology and Child Health ,Arterial spin labeling ,Neurology (clinical) ,Perfusion magnetic resonance imaging ,Nuclear medicine ,business ,Perfusion - Abstract
Arterial spin labeling is a fully noninvasive magnetic resonance perfusion imaging method, ideally suited to pediatric perfusion imaging. We describe an 8-year-old boy with sickle cell disease, extensive right-hemispheric cerebral infarction, and crossed-cerebellar diaschisis apparent on arterial spin labeling perfusion magnetic resonance imaging. To our knowledge, this is the first case of crossed-cerebellar diaschisis demonstrated with arterial spin labeling, highlighting the potential value of perfusion magnetic resonance imaging in the clinical evaluation and follow-up of crossed-cerebellar diaschisis, and the suitability of arterial spin labeling methods for routine perfusion imaging in pediatric patients.
- Published
- 2010
- Full Text
- View/download PDF
18. Platform Session – Evoked potentials & NIOM: Somatosensory evoked potentials and central motor conduction times help predict outcomes from deep brain stimulation (DBS) in children with dystonia
- Author
-
Hortensia Gimeno, Richard Selway, Markus C. Elze, Kerry R. Mills, Ata Siddiqui, Denise Flexney-Briscoe, Verity M. McClelland, Doreen Fialho, Graham E. Holder, and Jean-Pierre Lin
- Subjects
Dystonia ,medicine.medical_specialty ,Deep brain stimulation ,business.industry ,medicine.medical_treatment ,Audiology ,medicine.disease ,Sensory Systems ,Neuromodulation (medicine) ,Median nerve ,Transcranial magnetic stimulation ,medicine.anatomical_structure ,Neurology ,Somatosensory evoked potential ,Physiology (medical) ,Scalp ,Medicine ,Neurology (clinical) ,business ,Motor cortex - Abstract
Introduction DBS of the Globus pallidus internus has dramatic benefits in primary dystonia. Responsiveness of secondary dystonia is more modest and varies markedly between individuals. Predictive markers are lacking and the underlying pathophysiology of secondary dystonia is poorly understood. We report Somatosensory Evoked Potentials (SEPs) and Central Motor Conduction Times (CMCT) in children with dystonia and test the hypothesis that these parameters relate to outcome from DBS. Methods Data were obtained from 180 consecutive children with dystonia undergoing multidisciplinary DBS assessment (mean age 10 years; range 2.5–19). Transcranial Magnetic Stimulation was applied to motor cortex and Motor Evoked Potentials were recorded in the activated contralateral hand and foot muscles. CMCT to each limb was calculated using the F-wave method. Median nerve SEPs were recorded over ipsilateral Erb’s point, 7th and 2nd cervical vertebrae and contralateral centroparietal scalp. Posterior tibial nerve SEPs were recorded over ipsilateral popliteal fossa and midline centroparietal scalp. A mid-frontal reference was used. Electrical stimuli of 0.2millisecond duration were applied at 2.1 Hz, just above motor threshold. SEPs were classed as abnormal if delayed, absent or of abnormal waveform. Technically unsatisfactory recordings were excluded. Structural abnormalities were assessed with cranial MRI. Outcome from DBS at 1 year was assessed as percentage improvement in Burke-Fahn-Marsden Dystonia Rating Scale (BFMDRS-m). Results Of the 146 children with satisfactory CMCT data, 28(19%) had an abnormal CMCT to at least one limb. Of the 100 children with satisfactory cortical SEP data, 47 had at least one abnormal cortical potential. Abnormal CMCTs and SEPs were both observed more frequently in secondary than primary/primary plus dystonia (CMCT: 22% vs. 9%, SEP: 53% vs. 24%). Of children proceeding to DBS, improvement in BFMDRS-m was greater in those with normal (n = 78) than abnormal CMCT (n = 11) (Mann Whitney p = 0.002) and in those with normal (n = 35) versus abnormal SEPs (n = 16) (Mann Whitney p = 0.001). On sub-group analysis, these relationships were preserved regardless of aetiology (primary versus secondary) or cranial imaging (normal vs abnormal MRI). Conclusion CMCTs and SEPs provide objective evidence of motor and sensory pathway dysfunction in children with dystonia. Abnormal CMCTs and SEPs relate to DBS outcome, therefore contributing to patient selection and counselling of families about potential benefit from neuromodulation.
- Published
- 2018
- Full Text
- View/download PDF
19. Imaging of the pharynx and larynx
- Author
-
Ata Siddiqui and Steve Connor
- Subjects
Larynx ,medicine.medical_specialty ,medicine.diagnostic_test ,business.industry ,Mucosal lesions ,Pharynx ,Tumour staging ,Endoscopy ,Cross-sectional imaging ,medicine.anatomical_structure ,Biopsy ,medicine ,Radiology, Nuclear Medicine and imaging ,Radiology ,Stage (cooking) ,business - Abstract
An overwhelming majority of pharyngeal and laryngeal tumours are squamous cell carcinomas.A knowledge of the imaging anatomy and normal appearances of different tissues is crucial to diagnosis and staging.Early mucosal lesions can be easily missed on imaging and are best detected by direct visualization. Imaging appearances always require correlation with endoscopic appearances.Submucosal spread is best visualized on cross sectional imaging and the primary role of the radiologist is to accurately stage the extent of disease which directly influences treatment planning.Identification of cartilage involvement is crucial but is not without pitfalls.Both CT and MRI are widely used for tumour staging and are sometimes complementary.Post treatment imaging appearances can mimic tumour. Endoscopy, follow up imaging, PET imaging and biopsy all play a complementary role.Perineural and intracranial extension is often seen with nasopharyngeal and occasionally oropharyngeal tumours. The radiologist should be alert to ...
- Published
- 2007
- Full Text
- View/download PDF
20. Somatosensory evoked potentials in children with dystonia help predict outcome from deep brain stimulation
- Author
-
Jean-Pierre Lin, Richard Selway, Graham E. Holder, Verity M. McClelland, Doreen Fialho, Denise Flexney-Briscoe, Markus C. Elze, Hortensia Gimeno, Kerry R. Mills, and Ata Siddiqui
- Subjects
Dystonia ,Deep brain stimulation ,business.industry ,Somatosensory evoked potential ,medicine.medical_treatment ,Pediatrics, Perinatology and Child Health ,medicine ,Neurology (clinical) ,General Medicine ,business ,medicine.disease ,Neuroscience - Published
- 2017
- Full Text
- View/download PDF
21. Raised Intracranial Pressure Due to Compression of the Jugular Vein in Wegener's Granulomatosis
- Author
-
Tania Elias, David D'Cruz, Gordon T. Plant, Ata Siddiqui, and Dominic C Paviour
- Subjects
Wegener s ,medicine.medical_specialty ,business.industry ,Context (language use) ,Compression (physics) ,Extrinsic compression ,Constriction ,Raised intracranial pressure ,Ophthalmology ,Jugular vein ,cardiovascular system ,medicine ,Neurology (clinical) ,Radiology ,business ,Intracranial pressure - Abstract
The pseudotumor cerebri syndrome (PTCS) arises as a consequence of raised intracranial pressure in the absence of a space occupying lesion. It can be associated with poor cranial cerebral venous outflow, typically in the context of venous sinus thrombosis. Increased intracranial pressure secondary to extrinsic compression and constriction of the jugular veins by inflammatory or fibrotic tissue is rare. We describe this phenomenon as a consequence of Wegener's granulomatosis (WG) in which venous compression is confirmed using non-invasive cranial imaging.
- Published
- 2008
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.